Multimodal Assessment of Cardiac Sympathetic Nervous System Remodeling and Neurohormonal Modulation Following Transcatheter Mitral Valve Edge-to-Edge Repair: Insights from Quantitative ¹²³I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Patients with Disproportionate Secondary Mitral Regurgitation and Advanced Ventricular-Myocardial Uncoupling
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Abstract Background: Secondary mitral regurgitation (SMR) in heart failure with reduced ejection fraction (HFrEF) is linked to progressive cardiac sympathetic nervous system (CSNS) hyperactivity, adverse left ventricular (LV) remodeling, and poor prognosis. The disproportionate SMR phenotype—where effective regurgitant orifice area (EROA) exceeds that expected from LV dilatation—and advanced ventricular-myocardial uncoupling (evidenced by impaired global longitudinal strain [GLS] relative to LV geometry) identify patients likely to derive substantial benefit from transcatheter edge-to-edge repair (TEER). However, the impact of TEER on CSNS remodeling, quantified by ¹²³I-MIBG scintigraphy, and its integration with multimodal imaging and neurohormonal biomarkers remain incompletely characterized. Methods: In this prospective, single-center study, 62 patients with symptomatic disproportionate SMR (EROA ≥0.3 cm² and EROA/LVEDV ratio >0.15 cm²/mL) and advanced uncoupling (absolute GLS ≥−12% or myocardial work efficiency
Fields of Study & Subjects
Cardiac Valve Diseases and Treatments
Cardiac Imaging and Diagnostics
Cardiovascular Function and Risk Factors
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 26 March 2026
- Language
- EN